Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Prevalence and the Prognostic Value of Sarcopenia Among Patients With Haematological Cancer Diseases - A Prospective Observational Cohort Study.

Authors not listed

Copenhagen University Hospital, Rigshospitalet · 2023

Dysbiosis Human Randomized controlled trial Cohort study

Abstract

PURPOSE: To evaluate the prevalence and prognostic value of sarcopenia in patients diagnosed with hematological cancer diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2023). The Prevalence and the Prognostic Value of Sarcopenia Among Patients With Haematological Cancer Diseases - A Prospective Observational Cohort Study. <em>Copenhagen University Hospital, Rigshospitalet</em>. https://clinicaltrials.gov/study/NCT05150561

Vancouver

Anonymous. The Prevalence and the Prognostic Value of Sarcopenia Among Patients With Haematological Cancer Diseases - A Prospective Observational Cohort Study. Copenhagen University Hospital, Rigshospitalet. 2023.

BibTeX

@misc{anon2023ThePre, title = {The Prevalence and the Prognostic Value of Sarcopenia Among Patients With Haematological Cancer Diseases - A Prospective Observational Cohort Study.}, author = {Anonymous}, journal = {Copenhagen University Hospital, Rigshospitalet}, year = {2023}, }